Harshal Deshmukh
Overview
Explore the profile of Harshal Deshmukh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1054
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kamruzzaman M, Horowitz M, Rahman M, Deshmukh H, Jones K, Marathe C
J Diabetes Investig
. 2025 Mar;
PMID: 40083113
Background: Food insecurity (FIS) affects around 25% of Bangladesh's population, and data from developed nations report higher FIS rates among individuals with type 2 diabetes (T2D), potentially worsening glycemic control....
2.
Nadarajah N, Ssemmondo E, Brooks S, Akinyombo R, Adeleke K, Deshmukh H, et al.
Int J Endocrinol Metab
. 2025 Jan;
22(3):e147825.
PMID: 39839805
Background: Growth hormone replacement is indicated in adults with severe growth hormone (GH) deficiency, adult growth hormone deficiency assessment (AGHDA) score of at least 11 and are receiving treatment for...
3.
Konantambigi A, Al-Abbood M, Weich B, Barra D, Hiskens M, Marathe C, et al.
Intern Med J
. 2025 Jan;
PMID: 39825477
Background: Type 2 diabetes mellitus (T2DM) poses a significant public health challenge in Australia, particularly among underserved populations such as First Nations people and rural communities. In response, the Together...
4.
Magavern E, Deshmukh H, Asselin G, Theusch E, Trompet S, Li X, et al.
Pharmacol Res
. 2025 Jan;
212:107575.
PMID: 39798939
Statins are first-line treatments in the primary and secondary prevention of cardiovascular disease. Clinical studies show statins act independently of lipid-lowering mechanisms to decrease C-reactive protein (CRP), an inflammation marker....
5.
Deshmukh H, Wilmot E, Choudhary P, Ssemmondo E, Barnes D, Walker N, et al.
Diabetes Care
. 2025 Jan;
48(3):437-443.
PMID: 39746160
Objective: This study aimed to explore the relationship between time below range (TBR), impaired awareness of hypoglycemia (IAH), and severe hypoglycemia (SH). Research Design And Methods: This cross-sectional study analyzed...
6.
Ssemmondo E, Shah N, Newham M, Rigby A, Buckland R, Deshmukh H, et al.
Diabetes Obes Metab
. 2024 Dec;
27(3):1226-1232.
PMID: 39663609
Aims: This pilot randomised controlled trial aimed to evaluate the effect of introducing isCGM on glycaemic control and diabetes distress in individuals with T2DM receiving non-insulin therapies. Materials And Methods:...
7.
Deshmukh H, Ssemmondo E, Adeleke K, Mongolu S, Aye M, Orme S, et al.
Clin Endocrinol (Oxf)
. 2024 Jul;
101(3):274-281.
PMID: 39012017
Objective: This study aimed to understand the effect of time to remission of acromegaly on survival in people living with acromegaly. Design, Patients And Measurement: This cross-sectional study used data...
8.
Abdalla M, Shah N, Deshmukh H, Sahebkar A, Ostlundh L, Al-Rifai R, et al.
Adv Ther
. 2024 Apr;
41(6):2168-2195.
PMID: 38683294
Introduction: Polycystic ovary syndrome (PCOS) is a complex endocrine condition affecting women of reproductive age. It is characterised by insulin resistance and is a risk for type 2 diabetes mellitus...
9.
Ssemmondo E, Deshmukh H, Wilmot E, Adeleke K, Shah N, Walton C, et al.
Diabetes Obes Metab
. 2024 Jan;
26(4):1340-1345.
PMID: 38228571
Aim: To understand the effect of intermittently scanned continuous glucose monitoring (isCGM) in people with diabetes with a 'psychosocial' indication for access. Methods: The study utilized baseline and follow-up data...
10.
Deshmukh H, Adeleke K, Wilmot E, Folwell A, Barnes D, Walker N, et al.
Diabetes Obes Metab
. 2024 Jan;
26(4):1333-1339.
PMID: 38164758
Aims: To evaluate the clinical features and impact of flash glucose monitoring in older adults with type 1 diabetes (T1D) across age groups defined as young-old, middle-old, and old-old. Materials...